Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-8-3
pubmed:abstractText
The Na(+)-K(+)-ATPase (NKA) is a transmembrane protein that sets and maintains the electrochemical gradient by extruding three Na(+) in exchange for two K(+). An important physiological role proposed for vascular smooth muscle NKA is the regulation of blood pressure via modulation of vascular smooth muscle contractility (5). To investigate the relations between the level of NKA in smooth muscle and blood pressure, we developed mice carrying a transgene for either the NKA alpha(1)- or alpha(2)-isoform (alpha(1 sm+) or alpha(2 sm+) mice) driven by the smooth muscle-specific alpha-actin promoter SMP8. Interestingly, both alpha-isoforms, the one contained in the transgene and the one not contained, were increased to a similar degree at both protein and mRNA levels. The total alpha-isoform protein was increased from 1.5-fold (alpha(1 sm+) mice) to 7-fold (alpha(2 sm+) mice). The increase in total NKA alpha-isoform protein was accompanied by a 2.5-fold increase in NKA activity in alpha(2 sm+) gastric antrum. Immunocytochemistry of the alpha(1)- and alpha(2)-isoforms in alpha(2 sm+) aortic smooth muscle cells indicated that alpha-isoform distributions were similar to those shown in wild-type cells. alpha(2 sm+) Mice (high expression) were hypotensive (109.9 +/- 1.6 vs. 121.3 +/- 1.4 mmHg; n = 13 and 11, respectively), whereas alpha(1 sm+) mice (low expression) were normotensive (122.7 +/- 2.5 vs. 117.4 +/- 2.3; n = 11 or 12). alpha(2 sm+) Aorta, but not alpha(1 sm+) aorta, relaxed faster from a KCl-induced contraction than wild-type aorta. Our results show that smooth muscle displays unique coordinate expression of the alpha-isoforms. Increasing smooth muscle NKA decreases blood pressure and is dependent on the degree of increased alpha-isoform expression.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0363-6135
pubmed:author
pubmed:issnType
Print
pubmed:volume
293
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
H1172-82
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:17468335-Actins, pubmed-meshheading:17468335-Animals, pubmed-meshheading:17468335-Aorta, pubmed-meshheading:17468335-Blood Pressure, pubmed-meshheading:17468335-Dose-Response Relationship, Drug, pubmed-meshheading:17468335-Enzyme Inhibitors, pubmed-meshheading:17468335-Hypotension, pubmed-meshheading:17468335-Kinetics, pubmed-meshheading:17468335-Mice, pubmed-meshheading:17468335-Mice, Transgenic, pubmed-meshheading:17468335-Muscle, Smooth, Vascular, pubmed-meshheading:17468335-Ouabain, pubmed-meshheading:17468335-Phenylephrine, pubmed-meshheading:17468335-Potassium Chloride, pubmed-meshheading:17468335-Promoter Regions, Genetic, pubmed-meshheading:17468335-Pyloric Antrum, pubmed-meshheading:17468335-RNA, Messenger, pubmed-meshheading:17468335-Sodium-Potassium-Exchanging ATPase, pubmed-meshheading:17468335-Up-Regulation, pubmed-meshheading:17468335-Vasoconstriction, pubmed-meshheading:17468335-Vasoconstrictor Agents
pubmed:year
2007
pubmed:articleTitle
Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure.
pubmed:affiliation
Department of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0576, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural